| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rosa Cortese, Marco Battaglini, Ferran Prados, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Jens Wuerfel, Romain Marignier, Françoise Durand-Dubief, Carolina de Medeiros Rimkus, Dagoberto Callegaro, Douglas Kazutoshi Sato, Massimo Filippi, Maria Assunta Rocca, Laura Cacciaguerra, Alex Rovira, Jaume Sastre-Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriu, Maria Sepulveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth G Celius, Anne-Katrin Proebstel, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Luca Carmisciano, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano, Olga Ciccarell. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults. Brain : a journal of neurology. 2022-12-14. PMID:36515653. |
mri and clinical features of myelin oligodendrocyte glycoprotein (mog)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for mog-antibodies is unavailable or shows uncertain results. |
2022-12-14 |
2023-08-14 |
Not clear |
| Yi-Long Wang, Meng-Ying Zhu, Zhe-Feng Yuan, Xiao-Yan Ren, Xiao-Tong Guo, Yi Hua, Lu Xu, Cong-Ying Zhao, Li-Hua Jiang, Xin Zhang, Guo-Xia Sheng, Pei-Fang Jiang, Zheng-Yan Zhao, Feng Ga. Proteomic profiling of cerebrospinal fluid in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. World journal of pediatrics : WJP. 2022-12-12. PMID:36507981. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad) is an autoimmune demyelinating disorder of the central nervous system. |
2022-12-12 |
2023-08-14 |
Not clear |
| Antonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, Marcello Moccia, Matteo Gastaldi, Rosa Iodice, Enrico Tedeschi, Maria Petracca, Luigi Lavorgna, Alessandro d'Ambrosio, Vincenzo Brescia Morra, Roberta Lanzill. AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature. International journal of molecular sciences. vol 23. issue 23. 2022-12-11. PMID:36498887. |
(1) the co-occurrence of aqp4 and myelin oligodendrocyte glycoprotein (mog) antibodies in patients with demyelinating disorders is extremely rare. |
2022-12-11 |
2023-08-14 |
Not clear |
| Minghui Wu, Qi Kang, Yuezhi Kang, Yanping Tong, Tao Yang, Yongping Fa. Catalpol Regulates Oligodendrocyte Regeneration and Remyelination by Activating the GEF-Cdc42/Rac1 Signaling Pathway in EAE Mice. Evidence-based complementary and alternative medicine : eCAM. vol 2022. 2022-12-09. PMID:36482934. |
the current study aimed to investigate the direct protective effects of catalpol on demyelination damage induced by myelin oligodendrocyte glycoprotein (mog) immunization and to explore whether the gef-cdc42/rac1 signaling pathway contributes to the regeneration effect induced by catalpol. |
2022-12-09 |
2023-08-14 |
mouse |
| Jamie Jacobs, Priscilla Vu, Antonio K Li. A Patient With Myelin Oligodendrocyte Glycoprotein Positive Encephalitis With Ring Enhancing Lesions on Magnetic Resonance Imaging (MRI) After COVID-19 Exposure. Cureus. vol 14. issue 11. 2022-11-30. PMID:36447808. |
myelin oligodendrocyte glycoprotein (mog) antibody has been associated with a wide range of neurological diseases, from neuromyelitis optica spectrum disorder to acute disseminated encephalomyelitis. |
2022-11-30 |
2023-08-14 |
Not clear |
| Dariush Haghmorad, Bahman Yousefi, Majid Eslami, Ali Rashidy-Pour, Mahdieh Tarahomi, Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, Aleksandr Kamyshnyi, Valentyn Oksenyc. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Current issues in molecular biology. vol 44. issue 11. 2022-11-24. PMID:36421672. |
therefore, we investigated the efficacy of oral administration of a myelin oligodendrocyte glycoprotein (mog) in the treatment of eae. |
2022-11-24 |
2023-08-14 |
mouse |
| Darius Mewes, Joseph Kuchling, Patrick Schindler, Ahmed Abdelrahim Ahmed Khalil, Sven Jarius, Friedemann Paul, Claudia Chie. Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) and MOG Antibody-Associated Disease (MOGAD). Klinische Monatsblatter fur Augenheilkunde. vol 239. issue 11. 2022-11-21. PMID:36410333. |
aquaporin-4 antibody-seropositive neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad; also termed mog encephalomyelitis) are autoimmune diseases of the central nervous system. |
2022-11-21 |
2023-08-14 |
Not clear |
| Yuanhua Cai, Jocelyn A Schroeder, Weiqing Jing, Cody Gurski, Calvin B Williams, Shaoyuan Wang, Bonnie N Dittel, Qizhen Sh. Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis. Frontiers in immunology. vol 13. 2022-11-17. PMID:36389708. |
here, we report genetic engineering of hematopoietic stem cells (hscs) to express myelin oligodendrocyte glycoprotein (mog), specifically in platelets, as a means of intervention to induce immune tolerance in experimental autoimmune encephalomyelitis (eae), the mouse model of ms. |
2022-11-17 |
2023-08-14 |
mouse |
| Abhay Ranjan, Sanaullah Mudassir, Neetu Sinha, Ankit Panjwani, Ashok Kuma. Area Postrema Syndrome: An Initial Presentation of Double-Seropositive AQP4 and MOG Antibodies. Neurology. Clinical practice. vol 12. issue 4. 2022-11-16. PMID:36382120. |
we herein report a case of aps as an initial presentation of double-seropositive aquaporin-4 and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2022-11-16 |
2023-08-14 |
Not clear |
| Jue Shen, Donghui Lin, Tiejia Jiang, Feng Gao, Kewen Jian. Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China. BMC neurology. vol 22. issue 1. 2022-11-10. PMID:36352355. |
to explore the clinical characteristics and related factors of children with acute disseminated encephalomyelitis (adem) with positive anti-myelin oligodendrocyte glycoprotein (mog) antibody. |
2022-11-10 |
2023-08-14 |
Not clear |
| Rhonda R Voskuhl, Allan MacKenzie-Graha. Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis. Frontiers in molecular neuroscience. vol 15. 2022-11-07. PMID:36340686. |
ms and chronic eae induced in c57bl/6 mice using myelin oligodendrocyte glycoprotein (mog) peptide 35-55 share many neuropathologies. |
2022-11-07 |
2023-08-14 |
mouse |
| Pardis Sohrabi, Abdolhossein Parnow, Cyrus Jalil. Treadmill aerobic training improve beam-walking test, up-regulate expression of main proteins of myelin and myelination in the hippocampus of cuprizone-fed mice. Neuroscience letters. vol 792. 2022-11-07. PMID:36341924. |
the aim of this study was to investigate the effect of 6 weeks of aerobic training on the main proteins of myelin including myelin basic protein (mbp), myelin oligodendrocyte (mog), myelin associated glycoprotein (mag), and myelin proteolipid protein (plp) at hippocampus of c57bl/6 mouse model of cuprizone-induced ms. twenty-eight female c57bl/6 mice (23 ± 3 g) were randomly divided into four groups (n = 7 per group): control, exercise (exe), cuprizone (cpz), and cuprizone with exercise (cpz + exe). |
2022-11-07 |
2023-08-14 |
mouse |
| Marta Gilardi, Antonio Cortese, Elisabetta Ferraro, Marco Rispoli, Riccardo Sadun, Maria Concetta Altavista, Federico Sadu. MOG-IgG positive optic neuritis after SARS-CoV-2 infection. European journal of ophthalmology. 2022-11-01. PMID:36317310. |
many neurologic complications have been described after severe acute respiratory syndrome coronavirus-2 (sars-cov-2) including atypical cases of optic neuritis (on), positive to myelin oligodendrocyte glycoprotein (mog) igg. |
2022-11-01 |
2023-08-14 |
Not clear |
| Numfon Khemthongcharoen, Panapat Uawithya, Nutthapon Yookong, Mayuree Chanasakulniyom, Wutthinan Jeamsaksiri, Witsaroot Sripumkhai, Pattaraluck Pattamang, Ekachai Juntasaro, Ampol Kamnerdsook, Nongluck Houngkamhang, Chamras Promptma. A simple and high -performance immobilization technique of membrane protein from crude cell lysate sample for a membrane-based immunoassay application. Journal of immunoassay & immunochemistry. 2022-11-01. PMID:36318041. |
immunofluorescence staining and the enzyme-linked immunosorbent assay (elisa) examination of a strictly conformation-dependent integral membrane protein, myelin oligodendrocyte glycoprotein (mog), demonstrate that luv incorporated cell lysate sample obviously promotes mog protein immobilization in the microplate well. |
2022-11-01 |
2023-08-14 |
Not clear |
| Zina Alme. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT]. Harefuah. vol 161. issue 10. 2022-10-31. PMID:36315205. |
the understanding and the classification of atypical optic neuritis evolved significantly since the discovery of the anti-aquaporin4 (aqp4) and the anti-myelin oligodendrocyte glycoprotein (mog) antibodies as biomarkers and pathologic causes of neuromyelitis optica spectrum disorder (nmosd) and mog-associated disorder (mogad) respectively. |
2022-10-31 |
2023-08-14 |
Not clear |
| Gregorio Spagni, Bo Sun, Gabriele Monte, Elia Sechi, Raffaele Iorio, Amelia Evoli, Valentina Damat. Efficacy and safety of rituximab in myelin oligodendrocyte glycoprotein antibody-associated disorders compared with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry. 2022-10-25. PMID:36283808. |
rituximab (rtx) efficacy in patients with myelin oligodendrocyte glycoprotein (mog) antibody-associated disorders (mogads) is still poorly understood, though it appears to be lower than in aquaporin-4-igg-positive neuromyelitis optica spectrum disorders (aqp4-igg+nmosds). |
2022-10-25 |
2023-08-14 |
Not clear |
| Paige Sutton, Michael W Lutz, F Lee Hartsell, Dorlan Kimbrough, N Troy Tagg, Mark Skeen, Nicholas M Hudak, Christopher Eckstein, Suma Sha. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center. Journal of neuroimmunology. vol 373. 2022-10-22. PMID:36272183. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disease: presentation and outcomes of adults at a single center. |
2022-10-22 |
2023-08-14 |
Not clear |
| Woo-Jin Lee, Young Nam Kwon, Boram Kim, Jangsup Moon, Kyung-Il Park, Kon Chu, Jung-Joon Sung, Sang Kun Lee, Sung-Min Kim, Soon-Tae Le. MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes. Journal of neurology, neurosurgery, and psychiatry. 2022-10-19. PMID:36261287. |
we investigated the clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein (mog) antibody-associated autoimmune encephalitis (mogae) in adult patients. |
2022-10-19 |
2023-08-14 |
Not clear |
| Jaydip Ray Chaudhuri, Jui Jade Bagul, Alluri Swathi, Bhim Sen Singhal, N Chakradhar Reddy, Kiran Kumar Valla. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension: A Case Report. Neurology(R) neuroimmunology & neuroinflammation. vol 9. issue 6. 2022-10-19. PMID:36261298. |
the production of autoantibodies against myelin oligodendrocyte glycoprotein (mog) can cause a spectrum of autoimmune disorders, including optic neuritis, transverse myelitis, brainstem encephalitis, and acute disseminated encephalomyelitis. |
2022-10-19 |
2023-08-14 |
Not clear |
| Marziyeh Soltani, Pezhman Beshkar, Kobra Mokhtarian, Maryam Anjomshoa, Mina Mohammad-Rezaei, Fatemeh Azadegan-Dehkordi, Yousef Mirzaei, Jafar Majidi, Nader Bagher. A Study of Autoantibodies against Some Central Nervous System Antigens and the IL-35 Serum Level in Schizophrenia. Iranian journal of allergy, asthma, and immunology. vol 21. issue 4. 2022-10-16. PMID:36243932. |
autoantibodies against n-methyl-d-aspartate receptor (nmdar) and myelin-associated glycoprotein (mag) were positive in 15% (6/40) and 7.5% (3/40), respectively; however, no antibodies against myelin, aquaporin-4 (aqp4), myelin oligodendrocyte glycoprotein (mog), voltage-gated potassium channel (vgkc), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (ampar), γ-butyric acid receptor type b1 γ-butyric acid receptor type b1 (gababr), antidipeptidyl peptidase-like protein-6 (dppx), immunoglobulin-like cell adhesion molecule 5 (iglon5), glycine receptor (r) and acetylcholine receptor (ach r) were detected (no statistics were computed). we found that decreased serum il-35 levels and the existence autoantibodies against nmdar antigen may contribute to the pathogenesis of scz. |
2022-10-16 |
2023-08-14 |
human |